SCHEMBL8502352

SCHEMBL8502352

CCCCCCCCOCC(=O)[C@@]12OC(CCC)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 9/20 0.62
▸ PGR P06401 4/20 0.44
▸ CYP3A4 P08684 3/20 0.44
▸ AR P10275 3/20 0.44
▸ USP2 O75604 1/20 0.44
▸ HIF1A Q16665 3/20 0.42
▸ LMNA P02545 3/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ESR1 P03372 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7204193 0.91 NR3C1 (0.60) NR3C1PGRCYP3A4ARUSP2
SCHEMBL8499719 0.91 NR3C1 (0.60) NR3C1PGRCYP3A4ARUSP2
SCHEMBL29714128 0.91 NR3C1 (0.60) NR3C1PGRCYP3A4ARUSP2
SCHEMBL8500279 0.91 NR3C1 (0.60) NR3C1PGRCYP3A4ARUSP2
SCHEMBL8501586 0.90 NR3C1 (0.60) NR3C1PGRCYP3A4ARUSP2
SCHEMBL8499360 0.90 NR3C1 (0.61) NR3C1PGRCYP3A4ARUSP2
SCHEMBL8499567 0.89 NR3C1 (0.64) NR3C1PGRCYP3A4ARUSP2
SCHEMBL8503589 0.88 NR3C1 (0.63) NR3C1PGRCYP3A4ARUSP2
Rofleponide SCHEMBL23803954 0.88 NR3C1 (0.68) NR3C1PGRCYP3A4ARHIF1A
Rofleponide SCHEMBL7196822 0.88 NR3C1 (0.68) NR3C1PGRCYP3A4ARHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5888995-A ANTIINFLAMMATORY AND ANTIALLERGENIC AGENTS; A NOVEL GLUCOCORTICOSTEROID ASTRA AKTIEBOLAG (SE) 1999-03-30 — — US disclosed
Send feedback